{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:27:42Z","timestamp":1792697262119,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A particular challenge in the development of a bipolar disorder (BD) model in animals is the complicated clinical course of the condition, characterized by manic, depressive and mixed mood episodes. Ouabain (OUA) is an inhibitor of Na<jats:sup>+<\/jats:sup>\/K<jats:sup>+<\/jats:sup>-ATPase enzyme. Intracerebroventricular (ICV) injection of this drug in rats has been regarded a proper model to study BD by mimic specific manic symptoms, which are reversed by lithium (Li), an important mood stabilizer drug. However, further validation of this experimental approach is required to characterize it as an animal model of BD, including depressive-like behaviors. The present study aimed to assess manic- and depressive-like behaviors, potential alteration in the hypothalamic-pituitary-adrenal (HPA) system and oxidative stress parameters after a single OUA ICV administration in adult male Wistar rats. Moreover, we evaluated Li effects in this experimental setting. Data show that OUA ICV administration could constitute a suitable model for BD since the injection of the drug triggered manic- and depressive-like behaviors in the same animal. Additionally, the OUA model mimics significant physiological and neurochemical alterations detected in BD patients, including an increase in oxidative stress and change in HPA axis. Our findings suggest that decreased Na<jats:sup>+<\/jats:sup>\/K<jats:sup>+<\/jats:sup>-ATPase activity detected in bipolar patients may be linked to increased secretion of glucocorticoid hormones and oxidative damage, leading to the marked behavioral swings. The Li administration mitigated these pathological changes in the rats. The proposed OUA model is regarded as suitable to simulate BD by complying with all validities required to a proper animal model of the psychiatric disorder.<\/jats:p>","DOI":"10.1038\/s41398-019-0494-6","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T17:02:47Z","timestamp":1559667767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Validation of the animal model of bipolar disorder induced by Ouabain: face, construct and predictive perspectives"],"prefix":"10.1038","volume":"9","author":[{"given":"Samira S.","family":"Valvassori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo C.","family":"Dal-Pont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson R.","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger B.","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica","family":"Lopes-Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Henrique","family":"Cararo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3114-6611","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"key":"494_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fpsyt.2014.00098","volume":"5","author":"V Maletic","year":"2014","unstructured":"Maletic, V. & Raison, C. Integrated neurobiology of bipolar disorder. Front. Psychiatry 5, 98 (2014).","journal-title":"Front. Psychiatry"},{"key":"494_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1515\/hsz-2015-0257","volume":"397","author":"YM Naaldijk","year":"2016","unstructured":"Naaldijk, Y. M., Bittencourt, M. C., Sack, U. & Ulrich, H. Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis. Biol. Chem. 397, 283\u2013296 (2016).","journal-title":"Biol. Chem."},{"key":"494_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000480349","volume":"3","author":"A Saxena","year":"2017","unstructured":"Saxena, A. et al. Role of protein kinase C in bipolar disorder: a review of the current literature. Mol. Neuropsychiatry 3, 108\u2013124 (2017).","journal-title":"Mol. Neuropsychiatry"},{"key":"494_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuroscience.2015.08.016","volume":"321","author":"T Kato","year":"2016","unstructured":"Kato, T., Kasahara, T., Kubota-Sakashita, M., Kato, T. M. & Nakajima, K. Animal models of recurrent or bipolar depression. Neuroscience 321, 189\u2013196 (2016).","journal-title":"Neuroscience"},{"key":"494_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuroscience.2015.08.041","volume":"321","author":"RW Logan","year":"2016","unstructured":"Logan, R. W. & McClung, C. A. Animal models of bipolar mania: the past, present and future. Neuroscience 321, 163\u2013188 (2016).","journal-title":"Neuroscience"},{"key":"494_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pnpbp.2015.11.001","volume":"66","author":"AN Sharma","year":"2016","unstructured":"Sharma, A. N. et al. Modeling mania in preclinical settings: a comprehensive review. Prog. Neuropsychopharmacol. Biol. Psychiatry 66, 22\u201334 (2016).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"Suppl 2","key":"494_CR7","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1590\/1516-4446-2013-1168","volume":"35","author":"SS Valvassori","year":"2013","unstructured":"Valvassori, S. S., Budni, J., Varela, R. B. & Quevedo, J. Contributions of animal models to the study of mood disorders. Rev. Bras. Psiquiatr 35(Suppl 2), S121\u2013S131 (2013).","journal-title":"Rev. Bras. Psiquiatr"},{"key":"494_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.pnpbp.2003.10.015","volume":"28","author":"R Machado-Vieira","year":"2004","unstructured":"Machado-Vieira, R., Kapczinski, F. & Soares, J. C. Perspectives for the development of animal models of bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 209\u2013224 (2004).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"494_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/00008877-199000160-00001","volume":"1","author":"BA Ellenbroek","year":"1990","unstructured":"Ellenbroek, B. A. & Cools, A. R. Animal models with construct validity for schizophrenia. Behav. Pharm. 1, 469\u2013490 (1990).","journal-title":"Behav. Pharm."},{"key":"494_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1034\/j.1399-5618.2003.00053.x","volume":"5","author":"RS El-Mallakh","year":"2003","unstructured":"El-Mallakh, R. S. et al. Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disord. 5, 362\u2013365 (2003).","journal-title":"Bipolar Disord."},{"key":"494_CR11","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.neubiorev.2007.04.001","volume":"31","author":"L Herman","year":"2007","unstructured":"Herman, L., Hougland, T. & El-Mallakh, R. S. Mimicking human bipolar ion dysregulation models mania in rats. Neurosci. Biobehav. Rev. 31, 874\u2013881 (2007).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"494_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jpsychires.2009.11.002","volume":"44","author":"LK Jornada","year":"2010","unstructured":"Jornada, L. K. et al. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. J. Psychiatr. Res. 44, 506\u2013510 (2010).","journal-title":"J. Psychiatr. Res."},{"key":"494_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jpsychires.2010.05.011","volume":"45","author":"LK Jornada","year":"2011","unstructured":"Jornada, L. K. et al. Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania. J. Psychiatr. Res. 45, 162\u2013168 (2011).","journal-title":"J. Psychiatr. Res."},{"key":"494_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0006-3223(94)00201-D","volume":"37","author":"RS El-Mallakh","year":"1995","unstructured":"El-Mallakh, R. S. & Wyatt, R. J. The Na,K-ATPase hypothesis for bipolar illness. Biol. Psychiatry 37, 235\u2013244 (1995).","journal-title":"Biol. Psychiatry"},{"key":"494_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jpsychires.2015.04.009","volume":"65","author":"SS Valvassori","year":"2015","unstructured":"Valvassori, S. S. et al. Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania: mood stabilizers exert protective effects against ouabain-induced activation of the cell death pathway. J. Psychiatr. Res. 65, 63\u201370 (2015).","journal-title":"J. Psychiatr. Res."},{"key":"494_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF02815161","volume":"31","author":"R Li","year":"1997","unstructured":"Li, R., El-Mallakh, R. S., Harrison, L., Changaris, D. G. & Levy, R. S. Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression. Mol. Chem. Neuropathol. 31, 65\u201372 (1997).","journal-title":"Mol. Chem. Neuropathol."},{"key":"494_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0306-9877(83)90042-7","volume":"12","author":"RS El-Mallakh","year":"1983","unstructured":"El-Mallakh, R. S. The Na,K-ATPase hypothesis for manic-depression. I. General considerations. Med. Hypotheses 12, 253\u2013268 (1983).","journal-title":"Med. Hypotheses"},{"key":"494_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.neuint.2009.05.003","volume":"55","author":"RE Riegel","year":"2009","unstructured":"Riegel, R. E. et al. Animal model of mania induced by ouabain: evidence of oxidative stress in submitochondrial particles of the rat brain. Neurochem. Int. 55, 491\u2013495 (2009).","journal-title":"Neurochem. Int."},{"key":"494_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijdevneu.2010.02.002","volume":"28","author":"RE Riegel","year":"2010","unstructured":"Riegel, R. E. et al. Intracerebroventricular ouabain administration induces oxidative stress in the rat brain. Int J. Dev. Neurosci. 28, 233\u2013237 (2010).","journal-title":"Int J. Dev. Neurosci."},{"key":"494_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pbb.2014.11.014","volume":"128","author":"J Lopes-Borges","year":"2015","unstructured":"Lopes-Borges, J. et al. Histone deacetylase inhibitors reverse manic-like behaviors and protect the rat brain from energetic metabolic alterations induced by ouabain. Pharm. Biochem Behav. 128, 89\u201395 (2015).","journal-title":"Pharm. Biochem Behav."},{"key":"494_CR21","unstructured":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals 8th edn (National Academies Press, Washington (DC), 2011)."},{"key":"494_CR22","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn, 124\u2013125 (Amer Psychiatric Pub Incorporated, Washington, DC, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"494_CR23","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler, E. J. & Hyman, S. E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 13, 1161\u20131169 (2010).","journal-title":"Nat. Neurosci."},{"key":"494_CR24","unstructured":"Broadhurst, P. L. in Experiments in Personality. (ed Eysenck, H. J.) 31\u201371 (Routledge & Kegan Paul, London, 1960)."},{"key":"494_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt, R. D., Le Pichon, M. & Jalfre, M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730\u2013732 (1977).","journal-title":"Nature"},{"key":"494_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke, M. J., Rickels, M. & Lucki, I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121, 66\u201372 (1995).","journal-title":"Psychopharmacology"},{"key":"494_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0197-0186(02)00080-3","volume":"42","author":"GD Gamaro","year":"2003","unstructured":"Gamaro, G. D., Manoli, L. P., Torres, I. L., Silveira, R. & Dalmaz, C. Effects of chronic variate stress on feeding behavior and on monoamine levels in different rat brain structures. Neurochem. Int. 42, 107\u2013114 (2003).","journal-title":"Neurochem. Int."},{"key":"494_CR28","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/clinchem\/38.9.1654","volume":"38","author":"E Chapoteau","year":"1992","unstructured":"Chapoteau, E., Czech, B. P., Zazulak, W. & Kumar, A. First practical colorimetric assay of lithium in serum. Clin. Chem. 38, 1654\u20131657 (1992).","journal-title":"Clin. Chem."},{"key":"494_CR29","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1097\/00001756-200007140-00052","volume":"11","author":"AT Wyse","year":"2000","unstructured":"Wyse, A. T. et al. Methylmalonate administration decreases Na+,K+-ATPase activity in cerebral cortex of rats. Neuroreport 11, 2331\u20132334 (2000).","journal-title":"Neuroreport"},{"key":"494_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0003-2697(86)90640-8","volume":"157","author":"KM Chan","year":"1986","unstructured":"Chan, K. M., Delfert, D. & Junger, K. D. A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal. Biochem. 157, 375\u2013380 (1986).","journal-title":"Anal. Biochem."},{"key":"494_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/10715760500161546","volume":"39","author":"H Kimura","year":"2005","unstructured":"Kimura, H. et al. Rapid increase in serum lipid peroxide 4-hydroxynonenal (HNE) through monocyte NADPH oxidase in early endo-toxemia. Free Radic. Res. 39, 845\u2013851 (2005).","journal-title":"Free Radic. Res."},{"key":"494_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0076-6879(81)77046-0","volume":"77","author":"A Wendel","year":"1981","unstructured":"Wendel, A. Glutathione peroxidase. Methods Enzym. 77, 325\u2013333 (1981).","journal-title":"Methods Enzym."},{"key":"494_CR33","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0076-6879(85)13062-4","volume":"113","author":"I Carlberg","year":"1985","unstructured":"Carlberg, I. & Mannervik, B. Glutathione reductase. Methods Enzym. 113, 484\u2013490 (1985).","journal-title":"Methods Enzym."},{"key":"494_CR34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265\u2013275 (1951).","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"494_CR35","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1038\/sj.mp.4001018","volume":"7","author":"HK Manji","year":"2002","unstructured":"Manji, H. K. & Chen, G. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol. Psychiatry 7(Suppl 1), S46\u2013S56 (2002).","journal-title":"Mol. Psychiatry"},{"key":"494_CR36","first-page":"47","volume":"37","author":"H Einat","year":"2003","unstructured":"Einat, H., Belmaker, R. H. & Manji, H. K. New approaches to modeling bipolar disorder. Psychopharmacol. Bull. 37, 47\u201363 (2003).","journal-title":"Psychopharmacol. Bull."},{"key":"494_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1242\/dmm.001628","volume":"2","author":"O Malkesman","year":"2009","unstructured":"Malkesman, O., Austin, D. R., Chen, G. & Manji, H. K. Reverse translational strategies for developing animal models of bipolar disorder. Dis. Model Mech. 2, 238\u2013245 (2009).","journal-title":"Dis. Model Mech."},{"key":"494_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuropharm.2016.10.015","volume":"117","author":"SS Valvassori","year":"2017","unstructured":"Valvassori, S. S. et al. Lithium and valproate act on the GSK-3\u03b2 signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain. Neuropharmacology 117, 447\u2013459 (2017).","journal-title":"Neuropharmacology"},{"key":"494_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0031-9384(97)00457-5","volume":"63","author":"DJ Ruktanonchai","year":"1998","unstructured":"Ruktanonchai, D. J., El-Mallakh, R. S., Li, R. & Levy, R. S. Persistent hyperactivity following a single intracerebroventricular dose of ouabain. Physiol. Behav. 63, 403\u2013406 (1998).","journal-title":"Physiol. Behav."},{"key":"494_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000441244","volume":"85","author":"GA Fava","year":"2016","unstructured":"Fava, G. A. & Bech, P. The concept of euthymia. Psychother. Psychosom. 85, 1\u20135 (2016).","journal-title":"Psychother. Psychosom."},{"key":"494_CR41","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.neuroscience.2007.12.026","volume":"152","author":"R Silva","year":"2008","unstructured":"Silva, R. et al. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta. Neuroscience 152, 656\u2013669 (2008).","journal-title":"Neuroscience"},{"key":"494_CR42","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.biopha.2017.01.119","volume":"88","author":"G Mohseni","year":"2017","unstructured":"Mohseni, G. et al. Agmatine enhances the antidepressant-like effect of lithium in mouse forced swimming testthrough NMDA pathway. Biomed. Pharmacother. 88, 931\u2013938 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"494_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bmj.2.5508.262","volume":"2","author":"DM Shaw","year":"1966","unstructured":"Shaw, D. M. Mineral metabolism, mania, and melancholia. Br. Med. J. 2, 262\u2013267 (1966).","journal-title":"Br. Med. J."},{"key":"494_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.1.5479.71","volume":"1","author":"A Coppen","year":"1966","unstructured":"Coppen, A., Shaw, D. M., Malleson, A. & Costain, R. Mineral metabolism in mania. Br. Med. J. 1, 71\u201375 (1966).","journal-title":"Br. Med. J."},{"key":"494_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/(SICI)1520-6394(1997)5:2<53::AID-DA1>3.0.CO;2-6","volume":"5","author":"SW Looney","year":"1997","unstructured":"Looney, S. W. & El-Mallakh, R. S. Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depress Anxiety 5, 53\u201365 (1997).","journal-title":"Depress Anxiety"},{"key":"494_CR46","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.biopsych.2008.10.033","volume":"65","author":"I Goldstein","year":"2009","unstructured":"Goldstein, I. et al. Association between sodium- and potassium-activated adenosine triphosphatase alpha isoforms and bipolar disorders. Biol. Psychiatry 65, 985\u2013991 (2009).","journal-title":"Biol. Psychiatry"},{"key":"494_CR47","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/00207450290025978","volume":"112","author":"AR Kurup","year":"2002","unstructured":"Kurup, A. R. & Kurup, P. A. Membrane Na(+)-K+ATPase mediated cascade in bipolar mood disorder, major depressive disorder, and schizophrenia\u2013relationship to hemispheric dominance. Int. J. Neurosci. 112, 965\u2013982 (2002).","journal-title":"Int. J. Neurosci."},{"key":"494_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0006-3223(97)00343-0","volume":"44","author":"L Mynett-Johnson","year":"1998","unstructured":"Mynett-Johnson, L. et al. Evidence for an allelic association between bipolar disorder and a Na+, K+adenosine triphosphatase alpha subunit gene (ATP1A3). Biol. Psychiatry 44, 47\u201351 (1998).","journal-title":"Biol. Psychiatry"},{"key":"494_CR49","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0006-3223(97)00440-X","volume":"44","author":"AM Rose","year":"1998","unstructured":"Rose, A. M. et al. Alpha 2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol. Psychiatry 44, 892\u2013897 (1998).","journal-title":"Biol. Psychiatry"},{"key":"494_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1152\/physrev.1966.46.1.51","volume":"46","author":"AR Martin","year":"1966","unstructured":"Martin, A. R. Quantal nature of synaptic transmission. Physiol. Rev. 46, 51\u201356 (1966).","journal-title":"Physiol. Rev."},{"key":"494_CR51","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1152\/jn.1987.57.2.496","volume":"57","author":"M McCarren","year":"1987","unstructured":"McCarren, M. & Alger, B. E. Sodium-potassium pump inhibitors increase neuronal excitability in the rat hippocampal slice: role of a Ca2+-dependent conductance. J. Neurophysiol. 57, 496\u2013509 (1987).","journal-title":"J. Neurophysiol."},{"key":"494_CR52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1056\/NEJM198808183190706","volume":"319","author":"PW Gold","year":"1988","unstructured":"Gold, P. W., Goodwin, F. K. & Chrousos, G. P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress. N. Engl. J. Med. 319, 413\u2013420 (1988).","journal-title":"N. Engl. J. Med."},{"key":"494_CR53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrn1683","volume":"6","author":"ER de Kloet","year":"2005","unstructured":"de Kloet, E. R., Jo\u00ebls, M. & Holsboer, F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463\u2013475 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"494_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.yebeh.2013.10.020","volume":"38","author":"MF Juruena","year":"2014","unstructured":"Juruena, M. F. Early-life stress and HPA axis trigger recurrent adulthood depression. Epilepsy Behav. 38, 148\u2013159 (2014).","journal-title":"Epilepsy Behav."},{"key":"494_CR55","first-page":"296","volume":"172","author":"MJ Owens","year":"1993","unstructured":"Owens, M. J. & Nemeroff, C. B. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. Ciba Found. Symp. 172, 296\u2013308 (1993).","journal-title":"Ciba Found. Symp."},{"key":"494_CR56","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1371\/journal.pone.0003675","volume":"4","author":"CA Oomen","year":"2009","unstructured":"Oomen, C. A. et al. Opposite effects of early maternal deprivation on neurogenesis in male versus female rats. PLoS ONE 4, 3675\u20133680 (2009).","journal-title":"PLoS ONE"},{"key":"494_CR57","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1399-5618.2009.00717.x","volume":"11","author":"JF Wang","year":"2009","unstructured":"Wang, J. F., Shao, L., Sun, X. & Young, L. T. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 11, 523\u2013529 (2009).","journal-title":"Bipolar Disord."},{"key":"494_CR58","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/archgenpsychiatry.2010.22","volume":"67","author":"AC Andreazza","year":"2010","unstructured":"Andreazza, A. C., Shao, L., Wang, J. F. & Young, L. T. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch. Gen. Psychiatry 67, 360\u2013368 (2010).","journal-title":"Arch. Gen. Psychiatry"},{"key":"494_CR59","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/jnc.12316","volume":"127","author":"AC Andreazza","year":"2013","unstructured":"Andreazza, A. C., Wang, J. F., Salmasi, F., Shao, L. & Young, L. T. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J. Neurochem. 127, 552\u2013561 (2013).","journal-title":"J. Neurochem."},{"key":"494_CR60","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pnpbp.2011.12.006","volume":"37","author":"U Banerjee","year":"2012","unstructured":"Banerjee, U., Dasgupta, A., Rout, J. K. & Singh, O. P. Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 37, 56\u201361 (2012).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"494_CR61","first-page":"263","volume":"34","author":"AC Andreazza","year":"2009","unstructured":"Andreazza, A. C. et al. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J. Psychiatry Neurosci. 34, 263\u2013271 (2009).","journal-title":"J. Psychiatry Neurosci."},{"key":"494_CR62","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/0004867413481631","volume":"47","author":"PV Magalh\u00e3es","year":"2013","unstructured":"Magalh\u00e3es, P. V. et al. A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania. Aust. N. Z. J. Psychiatry 47, 564\u2013568 (2013).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"494_CR63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.expneurol.2012.10.024","volume":"240","author":"J Budni","year":"2013","unstructured":"Budni, J. et al. Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice. Exp. Neurol. 240, 112\u2013121 (2013).","journal-title":"Exp. Neurol."},{"key":"494_CR64","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1399-5618.2010.00827.x","volume":"12","author":"PS Brocardo","year":"2010","unstructured":"Brocardo, P. S. et al. Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain. Bipolar Disord. 12, 414\u2013424 (2010).","journal-title":"Bipolar Disord."},{"key":"494_CR65","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pnpbp.2013.01.007","volume":"43","author":"DS Mac\u00eado","year":"2013","unstructured":"Mac\u00eado, D. S. et al. Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: relevance as an animal model of mania. Prog. Neuropsychopharmacol. Biol. Psychiatry 43, 230\u2013237 (2013).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"494_CR66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4068\/cmj.2016.52.1.18","volume":"52","author":"A Muneer","year":"2016","unstructured":"Muneer, A. The neurobiology of bipolar disorder: an integrated approach. Chonnam Med. J. 52, 18\u201337 (2016).","journal-title":"Chonnam Med. J."},{"key":"494_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/pcn.12476","volume":"71","author":"E Sigitova","year":"2017","unstructured":"Sigitova, E., Fi\u0161ar, Z., Hroudov\u00e1, J., Cik\u00e1nkov\u00e1, T. & Raboch, J. Biological hypotheses and biomarkers of bipolar disorder. Psychiatry Clin. Neurosci. 71, 77\u2013103 (2017).","journal-title":"Psychiatry Clin. Neurosci."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0494-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0494-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0494-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T15:35:57Z","timestamp":1671204957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0494-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1038\/s41398-019-0494-6","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]},"assertion":[{"value":"11 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.Q. has the following declarations of interest: Clinical Research Support: Janssen Pharmaceutical (Clinical Trial), Allergan (Clinical Trial); Advisory Boards, Speaker Bureaus, Expert Witness, or Consultant: Daiichi Sankyo (Speaker Bureau); Patent, Equity, or Royalty: Instituto de Neurociencias Dr. Joao Quevedo (Stockholder); Other: Artmed Editora (Copyright), Artmed Panamericana (Copyright). The remaining authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"158"}}